En route to local glioblastoma treatment with temozolomide doped hyaluronan fibres: formulation and in vitro cell studies

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F23%3A10467117" target="_blank" >RIV/00064203:_____/23:10467117 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/23:10467117 RIV/00216208:11310/23:10467117 RIV/00216208:11110/23:10467117 RIV/00216275:25310/23:39920681 RIV/61383082:_____/23:00001308
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=t72iXgeJRX" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=t72iXgeJRX</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1039/d3md00261f" target="_blank" >10.1039/d3md00261f</a>

Result language
angličtina
Original language name
En route to local glioblastoma treatment with temozolomide doped hyaluronan fibres: formulation and in vitro cell studies
Original language description
We report the preparation, characterisation and in vitro tests of hyaluronan fibres containing up to 50 w/w% of temozolomide for local glyoblastoma treatment. These fibres form a hydrogel upon contact with cerebrospinal fluid on the treatment spot.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)